Unity Biotechnology, Inc. (UNBX) Research

Unity Biotechnology, Inc. functions as a biotechnology enterprise dedicated to creating innovative treatments aimed at slowing down, stopping, or even reversing illnesses associated with the aging process. A core component of their therapeutic development involves senolytic compounds, specifically designed to address various ocular (eye) and neurological conditions.

Market snapshot

Symbol
UNBX
Price
$0.06
Day change
0.00%
Market cap
$965.6K
52-week range
0.0487-3.1
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Biora Therapeutics, Inc. (BIOR)
  • Chia Tai Enterprises International Limited (CAIHF)
  • Epigenomics AG (EPGNF)
  • Evofem Biosciences, Inc. (EVFM)
  • Halberd Corporation (HALB)
  • Marizyme, Inc. (MRZM)
  • Neutra Corp. (NTRR)
  • Orgenesis Inc. (ORGS)

Open Unity Biotechnology, Inc. (UNBX) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.